igf-1 lr3 1mg IGF1-LR3 IGF-1 LR3 – Research Peptide

Daily Protocol: 1 to 2 mg subcutaneous injection once daily Alternate Protocol: 2 to 3 mg subcutaneous injection three times weekly Cycle Length: 8 to 12 weeks on Rest Period: 4 to 6 weeks off between cycles Cycles Per Year: 2 to 3 cycles recommended Injection Sites: Abdomen, outer thigh, or upper arm with rotation Cycling Recommendations Research suggests running GHK-Cu in cycles of 8 to 12 weeks followed by rest periods of 4 to 6 weeks

Some individuals see a difference after a single treatment, while others benefit from a short series spaced out over several weeks

Gamma interferon and tumor necrosis factor reverse interleukin-4 suppression of lymphokine activated killer induction

At one point do we refuse placebo injections

A beautifully uniform, remarkably translucent porcelain-like skin tone that can extend across the entire face and body through cumulative, scheduled IV drip sessions